Compare Agilent Technologies Inc (A) vs iShares MSCI Hong Kong ETF (EWH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs iShares MSCI Hong Kong ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while iShares MSCI Hong Kong ETF trades at $22.17. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares MSCI Hong Kong ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals.
| A | EWH | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $24.55 |
52-Week Low | $110.24 | $20.66 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
EWH trades at $22.71 with a 0.98% daily gain, showing neutral technical signals overall. The ETF tracks Hong Kong equities, with recent momentum in the Hang Seng Index providing support. Moving averages indicate bullish momentum while oscillators remain neutral. The fund declared a $0.35 dividend payable in June 2026, offering income potential alongside capital appreciation.
Outlook remains balanced with technical strength offset by valuation concerns. Key opportunities include Hong Kong market recovery and technology sector momentum, while risks involve Asian market volatility and geopolitical tensions. The neutral technical stance suggests waiting for clearer directional signals before establishing new positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →
